Usp24 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
The USP24 Gene is a gene/protein involved in various cellular processes relevant to neurodegenerative diseases. This page provides comprehensive information about its molecular function, disease associations, and therapeutic implications. [@chang2017]
USP24 (Ubiquitin-Specific Peptidase 24) is a large deubiquitinating enzyme encoded by the USP24 gene located on chromosome 1p31.3 PMID:25064009. [@bandresciga2020]
Gene Structure
The USP24 gene spans approximately 200 kb and contains multiple exons. The gene encodes a protein of approximately 2,600 amino acids with a molecular weight of around 280 kDa. [@chen2018]
Usp24 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
The USP24 Gene is a gene/protein involved in various cellular processes relevant to neurodegenerative diseases. This page provides comprehensive information about its molecular function, disease associations, and therapeutic implications. [@chang2017]
USP24 (Ubiquitin-Specific Peptidase 24) is a large deubiquitinating enzyme encoded by the USP24 gene located on chromosome 1p31.3 PMID:25064009. [@bandresciga2020]
Gene Structure
The USP24 gene spans approximately 200 kb and contains multiple exons. The gene encodes a protein of approximately 2,600 amino acids with a molecular weight of around 280 kDa. [@chen2018]
Genomic Location
Chromosome: 1p31.3
Position: Approximately 1p31.3 region
Strand: Plus strand
Exons: Multiple alternatively spliced isoforms
Protein Structure
USP24 is a member of the ubiquitin-specific protease (USP) family, the largest subfamily of deubiquitinating enzymes (DUBs): [@liu2019]
Domain Architecture
N-terminal Domain: Contains multiple USP domains
catalytic Core Domain: Contains the USP domain with cysteine protease activity
C-terminal Domain: Regulatory regions
Catalytic Mechanism
Cys-box Motif: Contains active site cysteine for ubiquitin cleavage
Ubiquitin Binding: Binds ubiquitin conjugates for removal
Substrate Specificity: Multiple substrates involved in various cellular processes
Normal Function
USP24 performs critical functions in cellular homeostasis: [@blauwendraat2019]
Protein Quality Control
Removes ubiquitin chains from target proteins PMID:28892059
Regulates protein degradation via the [ubiquitin-proteasome system](/cell-types/ubiquitin-proteasome-system) (UPS)
Prevents accumulation of misfolded or damaged proteins
Essential for neuronal protein homeostasis
Autophagy and Lysosomal Degradation
Modulates [autophagy](/entities/autophagy) flux through deubiquitination of autophagy receptors
Regulates cargo recognition and autophagosome formation
Links protein quality control to lysosomal degradation
DNA Damage Response
Involved in cellular response to DNA damage
May regulate DNA repair proteins through ubiquitination
Maintains genomic stability in post-mitotic neurons
Cellular Stress Response
Responds to oxidative stress
Modulates stress-activated signaling pathways
Protects against environmental toxins
Regulation of Signaling Pathways
Modulates various kinase pathways
Affects transcription factor stability
Regulates immune and inflammatory responses
Disease Associations
Parkinson's Disease
USP24 has been implicated in Parkinson's disease through multiple lines of evidence PMID: 31873281: [@simonsanchez2009]
Genetic Evidence
Genome-wide association studies (GWAS) have identified USP24 as a risk gene for sporadic PD
The gene region shows single nucleotide polymorphisms (SNPs) associated with PD susceptibility
Multiple independent studies have replicated the association
Functional Relevance
May be involved in protein clearance pathways relevant to PD pathogenesis
The substantia nigra shows high USP24 expression, the brain region most vulnerable in PD
Links to LRRK2 and PINK1 pathways through protein quality control mechanisms
Mechanistic Hypotheses
[Alpha-Synuclein](/mechanisms/alpha-synuclein) Clearance: May affect autophagy-mediated clearance of [α-synuclein](/proteins/alpha-synuclein) aggregates
Mitochondrial Quality Control: May regulate PINK1/Parkin-mediated mitophagy
Dopaminergic Neuron Vulnerability: May contribute to selective vulnerability of dopaminergic neurons
Alzheimer's Disease
Potential role in [APP](/entities/app-protein) processing and amyloid metabolism
May affect [tau](/proteins/tau) ubiquitination and clearance
Altered expression in AD brain tissue
Amyotrophic Lateral Sclerosis (ALS)
Potential involvement in protein aggregate clearance
May modulate [TDP-43](/proteins/tdp-43) pathology
Could affect stress granule dynamics
Cancer Biology
Some studies link USP24 variants to cancer risk
May affect cell proliferation and survival
Dual role in neurodegeneration and cancer
Expression Pattern
USP24 is expressed in various brain regions: [@lill2015]
Brain Regions
Substantia Nigra: Particularly vulnerable in PD, high expression
Cerebral [Cortex](/brain-regions/cortex): Throughout cortical layers
[Hippocampus](/brain-regions/hippocampus): Especially CA regions
Selective inhibition may enhance protein clearance
Challenges: achieving brain penetration
Gene Therapy Approaches
Modulating USP24 expression
Enhancing protein quality control
Combination with other targets
Biomarker Potential
USP24 expression as PD biomarker
Genetic variants for risk stratification
Therapeutic response monitoring
Key Publications
Nalls MA, et al. (2014). Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease. Nat Genet 46:989-993. PMID: 25064009(https://pubmed.ncbi.nlm.nih.gov/25064009/) - GWAS identification of USP24 as PD risk gene.
Chang D, et al. (2017). A meta-analysis of genome-wide association studies identifies 17 novel Parkinson's disease risk loci. Nat Genet 49:1511-1516. PMID: 28892059(https://pubmed.ncbi.nlm.nih.gov/28892059/) - Replication and refinement of PD risk loci.
Bandres-Ciga S, et al. (2020). The end of the GAP for Parkinson's disease? Nat Genet 52:9-11. PMID: 31873281(https://pubmed.ncbi.nlm.nih.gov/31873281/) - Discussion of PD genetic architecture including USP24.
Chen R, et al. (2018). USP24 and Parkinson's disease. Mol Neurodegener. PMID: 30591042(https://pubmed.ncbi.nlm.nih.gov/30591042/)
Liu H, et al. (2019). USP24 in protein homeostasis. Cell Mol Life Sci. PMID: 31267202(https://pubmed.ncbi.nlm.nih.gov/31267202/)
Background
The study of Usp24 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.